Anti-inflammatory activity of various agents producing hyperlipemia in rats.
D000284:Administration, Oral; D000818:Animals; D001808:Blood Vessels / Q000187:drug effects; D002351:Carrageenan; D003911:Dextrans; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D004487:Edema / Q000139:chemically induced; D004655:Emulsions; D005223:Fats / Q000627:therapeutic use; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005557:Formaldehyde; D005990:Glycerol / Q000627:therapeutic use; D007249:Inflammation / Q000188:drug therapy*; D009821:Oils / Q000494:pharmacology / Q000627:therapeutic use*; D009829:Oleic Acids / Q000627:therapeutic use; D010713:Phosphatidylcholines / Q000627:therapeutic use; D010743:Phospholipids / Q000627:therapeutic use; D011092:Polyethylene Glycols / Q000627:therapeutic use; D051381:Rats; D012701:Serotonin; D013012:Sorbitol / Q000627:therapeutic use; D013025:Glycine max; D013268:Stimulation, Chemical; D014280:Triglycerides / Q000097:blood; D014425:Turpentine
D003911:Dextrans; D004338:Drug Combinations; D004655:Emulsions; D005223:Fats; D005230:Fatty Acids, Nonesterified; D009821:Oils; D009829:Oleic Acids; D010713:Phosphatidylcholines; D010743:Phospholipids; D014280:Triglycerides; D005557:Formaldehyde; D012701:Serotonin; D011092:Polyethylene Glycols; D013012:Sorbitol; D002351:Carrageenan; D005990:Glycerol; D014425:Turpentine